Technical Analysis for MRNS - Marinus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 9.02 -3.94% -0.37
MRNS closed down 3.94 percent on Monday, March 18, 2024, on approximately normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Flat

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Outside Day Range Expansion 0.00%
20 DMA Resistance Bearish -3.94%
20 DMA Resistance Bearish 0.78%
20 DMA Resistance Bearish -4.45%
Shooting Star Candlestick Bearish -4.45%
Calm After Storm Range Contraction -4.45%
NR7 Range Contraction -4.45%
Lower Bollinger Band Walk Weakness -4.45%
Crossed Above 200 DMA Bullish -2.80%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 19 hours ago
Outside Day about 20 hours ago
Down 5% about 20 hours ago
Down 3% about 20 hours ago
Fell Below Previous Day's Low about 20 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing neuropsychiatric therapeutics. It offers Ganaxolone, a synthetic small molecule, which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures; and is in proof-of-concept Phase II clinical trial as a treatment for behaviors in the orphan indication Fragile X Syndrome in children. The company has a collaboration agreement with NovaMedica, LLC, as well as a license agreement with Purdue Neuroscience Company. Marinus Pharmaceuticals, Inc. was founded in 2003 and is headquartered in New Haven, Connecticut.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Alcohol Neuroscience Ketones Seizure Sedatives Fragile X Syndrome Pregnanes Neurosteroids

Is MRNS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.26
52 Week Low 5.5704
Average Volume 420,032
200-Day Moving Average 8.60
50-Day Moving Average 9.80
20-Day Moving Average 9.40
10-Day Moving Average 9.04
Average True Range 0.62
RSI (14) 44.44
ADX 27.66
+DI 15.06
-DI 26.12
Chandelier Exit (Long, 3 ATRs) 8.65
Chandelier Exit (Short, 3 ATRs) 10.00
Upper Bollinger Bands 10.25
Lower Bollinger Band 8.54
Percent B (%b) 0.28
BandWidth 18.17
MACD Line -0.20
MACD Signal Line -0.19
MACD Histogram -0.0128
Fundamentals Value
Market Cap 492.25 Million
Num Shares 54.6 Million
EPS -2.78
Price-to-Earnings (P/E) Ratio -3.24
Price-to-Sales 17.71
Price-to-Book 10.10
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.30
Resistance 3 (R3) 10.38 10.03 10.08
Resistance 2 (R2) 10.03 9.71 9.99 10.01
Resistance 1 (R1) 9.53 9.51 9.36 9.45 9.94
Pivot Point 9.18 9.18 9.10 9.14 9.18
Support 1 (S1) 8.68 8.86 8.51 8.60 8.10
Support 2 (S2) 8.33 8.66 8.29 8.03
Support 3 (S3) 7.83 8.33 7.96
Support 4 (S4) 7.75